Search

everythinglearnresearchcommunity

for

Search:↓

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Melatonin affects when and how certain genes work during the growth of goat hair follicles.

Removing a specific gene in certain skin cells causes hair loss on the body by disrupting normal hair development.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

sFRP4 partially inhibits hair regeneration, but the study needs clearer data analysis and better explanation of the process.

A protein called sFRP4 can partly inhibit hair growth.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

The compound was successfully made and shows potential for treating prostate cancer.

Thymosin β4 and VEGF are important for organ function and may help with blood vessel formation.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Higher RBP4 levels found in people with two types of hair loss.

Laser and light treatments show promise for hair growth but need more research.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Analog 23 is a promising compound for prostate cancer treatment.

A new compound that could treat various androgen-related conditions was created and analyzed.

A new compound was made that might help treat diseases related to male hormones.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.